Dr. Henry Wang MD

Recommended Articles

• Life Lessons After Multiple Misdiagnoses of Lymphoma

  28-year-old Jessica DeCristofaro had been coughing persistently and she was told by her doctor that it was a result of allergies. She even took medication for her supposed allergies over the course of two years. When the medication failed to improve her persistent cough, another doctor diagnosed her...

• 'Sophie the Brave' Fights Childhood T-Cell Lymphoma

  The story of 2-year-old Sophie Skiles and her arduous battle with T-cell lymphoma pulls at one’s heartstrings while also causing one to marvel at the faith of her Mom, Shelby.The public first learned of Sophie when a newscast about her was posted online October 20, 2017. (KLTB/abc) It soon made it...

• What are the Stages of Multiple Myeloma?

  This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...

• Lymphoma, the Persistence of Inspirational Women, and the Power of Language

  Each year, Leukemia and Blood Cancer New Zealand (LBC) sponsors their Blood Cancer Patient Forum. They invite speakers to bring them news about such topics as treatment advances and management of cancer from a fully developed psycho-social perspective. Essentially, they dish up good old-fashioned...

• Stanford University's Linebacker Ryan Beecher Must Now Tackle Lymphoma

  There's no doubt that Ryan Beecher is strong. If you want just watch one Stanford University football game, you'll see that and then some. However, he is now going to have to use a different type of strength in his battle against lymphoma.Ryan's storyWhile many had been following Ryan Beecher before...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...